| Presented by: | The University of Nebraska Medical Center, Center for Continuing Education |
| Lecturer | Several lecturers |
| Approximate duration: | Not available |
| Summary points: | In this text-based CME topic, the initial findings of the Prostate Cancer Prevention Trial are reviewed. The author explains how finasteride may affect prostate cancer detection and how a risk calculator can help evaluate prostate cancer risk. |
| Accreditation: | The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE provider number is 447-000-08-423-H04-P.
Expiration date: November 30, 2009. |
| Other: | Text-only CME. |
Finasteride and Prostate Cancer Prevention: The Latest Chapter
